BIM
GBT

BlackRock Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

BlackRock Investment Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.25M Buy
86,180
+1,532
+2% +$26.9K ﹤0.01% 2551
2016
Q3 		$1.95M Buy
84,648
+14,321
+20% +$273K ﹤0.01% 2179
2016
Q2 		$1.17M Buy
70,327
+46,486
+195% +$938K ﹤0.01% 2512
2016
Q1 		$378K Buy
23,841
+468
+2% +$8.32K ﹤0.01% 3003
2015
Q4 		$756K Sell
23,373
-11,722
-33% -$508K ﹤0.01% 2783
2015
Q3 		$1.48M Buy
+35,095
New +$1.66M ﹤0.01% 2292

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock Investment Management's GBT Position: Q4 2016 in Review

BlackRock Investment Management increased its Global Blood Therapeutics, Inc. (GBT) stake by 1.8% in Q4 2016, buying an estimated $26.9K and bringing the position to 86,180 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2551.

BlackRock Investment Management first reported a position in GBT in Q3 2015 and has held it in 6 quarters since. The position peaked at $1.95M in Q3 2016. 96 funds tracked by Wall St. Rank hold GBT as of Q4 2016.

  • BlackRock Investment Management held 86,180 shares of Global Blood Therapeutics, Inc. worth $1.25M as of Q4 2016.
  • BlackRock Investment Management bought 1,532 Global Blood Therapeutics, Inc. shares in Q4 2016, an estimated $26.9K.
  • Global Blood Therapeutics, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2551 holding.
  • BlackRock Investment Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Investment Management's Global Blood Therapeutics, Inc. position peaked at $1.95M in Q3 2016.
  • 96 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.